Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2012 (2012), Article ID 691528, 4 pages
http://dx.doi.org/10.1155/2012/691528
Clinical Study

Enhanced Vascular Endothelial Growth Factor Gene Expression in Ischaemic Skin of Critical Limb Ischaemia Patients

Vascular Surgery and Angiology Department, Getafe University Hospital, Carretera de Toledo km 12,500, 28905 Getafe, Madrid, Spain

Received 29 September 2011; Accepted 25 January 2012

Academic Editor: Arnon Blum

Copyright © 2012 Silvia Bleda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Shweiki, A. Itin, D. Soffer, and E. Keshet, “Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis,” Nature, vol. 359, no. 6398, pp. 843–845, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Liu, S. R. Cox, T. Morita, and S. Kourembanas, “Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5 enhancer,” Circulation Research, vol. 77, no. 3, pp. 638–643, 1995. View at Google Scholar · View at Scopus
  3. B. Barleon, S. Sozzani, D. Zhou, H. A. Weich, A. Mantovani, and D. Marme, “Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1,” Blood, vol. 87, no. 8, pp. 3336–3343, 1996. View at Google Scholar · View at Scopus
  4. K. S. Moulton, K. Vakili, D. Zurakowski et al., “Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 8, pp. 4736–4741, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, “Inter-society consensus for the management of peripheral arterial disease (TASC II),” Journal of Vascular Surgery, vol. 45, supplement 1, pp. S5–S67, 2007. View at Publisher · View at Google Scholar
  6. J. de Haro, F. Acin, A. Lopez-Quintana, A. Florez, E. Martinez-Aguilar, and C. Varela, “Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease,” Heart and Vessels, vol. 24, no. 5, pp. 321–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Stehr, I. Töpel, S. Müller et al., “VEGF: a surrogate marker for peripheral vascular disease,” European Journal of Vascular and Endovascular Surgery, vol. 39, no. 3, pp. 330–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Eklof, R. B. Rutherford, J. J. Bergan et al., “Revision of the CEAP classification for chronic venous disorders: consensus statement,” Journal of Vascular Surgery, vol. 40, no. 6, pp. 1248–1252, 2004. View at Publisher · View at Google Scholar
  9. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Luo, D. Wariaro, G. Lundberg, H. Blegen, and E. Wahlberg, “Vascular growth factor expression in a rat model of severe limb ischemia,” Journal of Surgical Research, vol. 108, no. 2, pp. 258–267, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Choksy, A. G. Pockley, Y. E. Wajeh, and P. Chan, “VEGF and VEGF receptor expression in human chronic critical limb ischaemia,” European Journal of Vascular and Endovascular Surgery, vol. 28, no. 6, pp. 660–669, 2004. View at Publisher · View at Google Scholar
  12. U. Palmer-Kazen, D. Wariaro, F. Luo, and E. Wahlberg, “Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia,” Journal of Vascular Surgery, vol. 39, no. 3, pp. 621–628, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Bello, F. Cailotto, D. Hanriot et al., “C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway,” Atherosclerosis, vol. 200, no. 2, pp. 286–293, 2008. View at Publisher · View at Google Scholar · View at Scopus